IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Hawaii

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Hawaii $ 4,494,694.93
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Cardax Pharmaceuticals, Inc. CDX-085 A novel drug from Cardax Pharmaceuticals, for inflammatory Disease $ 244,479.25  
Cellular Bioengineering Inc Bioengineered Artificial Cornea for Restoration of Vision $ 244,479.24  
Cellular Bioengineering Inc. (CBI) Technology for Secure and Accurate Delivery of Therapeutics and Dosage $ 244,479.24  
Cellular Bioengineering, Inc. Treatment and Removal of Absorbed Radioactive and Carcinogenic Chemicals $ 244,479.24  
Hawaii Biotech, Inc Dengue Recombinant Subunit Vaccine $ 244,479.24  
Hawaii Biotech, Inc West Nile Recombinant Subunit Vaccine $ 244,479.24  
Hoana Medical Inc Lifebed/Lifegurney Patient Vigilance System $ 244,479.25  
Nanopoint Inc. Implementation of novel microfluidics platform for infertility treatment $ 244,479.24  
Oceanit Laboratories Inc Nanovector Drug Delivery System $ 13,150.00 $ 74,808.50
Oceanit Laboratories, Inc Laser Actuated Transcranial Hemostasis (LATCH) $ 59,566.50 $ 30,865.00
Oceanit Laboratories, Inc Rapid Adverse Identifier For Drug and Evaluation Resource $ 244,479.25  
Pacific Biotech, LLC Identification and evaluation of a potent angiogensis inhibitor $ 148,891.50 $ 95,587.74
Panthera Biopharma LLC Discovery & Development of Anti-Viral small molecule therapeutics for flaviral infections. $ 152,793.50 $ 41,360.50
Panthera Biopharma LLC Development of a Multi-Valent recumbinant subunit for filovirus infections $ 138,685.00 $ 22,898.00
Panthera Biopharma LLC Discovery & Development ofsmall molecule  Anti-Toxin Therapeutics for Anthrax $ 244,479.25  
PANTHERA BIOPHARMA, LLC DISCOVERY AND DEVELOPMENT OF SMALL MOLECULE ANTI-TOXIN THERAPEUTICS FOR BOTULISM $ 193,647.50 $ 50,831.75
Skai Technologies LLC Development of Bioengineered Soft Tissue Graft Technology   $ 48,900.00
STI Medical System, LLC Colon Cancer (Colonocad) Program $ 175,582.50 $ 68,896.75
STI Medical Systems, LLC ULTRASIGHTHD® COLPOSCOPY SYSTEM w/ IMAGESENSE™ DIAGNOSTIC ENHANCEMENT TECHNOLOGIES $ 244,479.25  
TEAMPRAXIS, LLC Poplulation Health Management (PHM) Module of Allscripts Clinical Quality Solution (CQS) $ 100,313.50 $ 144,165.75
Tissue Genesis, Inc. Tissue Genesis / Adipose derived cell therapy and regenerative medicine $ 244,479.25  
Page Last Reviewed or Updated: 25-Mar-2014